Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-17-000933
Filing Date
2017-04-14
Accepted
2017-04-14 13:47:49
Documents
40
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K proteo_10k-123116.htm 10-K 383890
2 CERTIFICATION proteo_10k-ex3101.htm EX-31.1 7715
3 CERTIFICATION proteo_10k-ex3102.htm EX-31.2 7621
4 CERTIFICATION proteo_10k-ex032.htm EX-32 4270
  Complete submission text file 0001683168-17-000933.txt   1616254

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pteo-20161231.xml EX-101.INS 191511
6 XBRL SCHEMA FILE pteo-20161231.xsd EX-101.SCH 15164
7 XBRL CALCULATION FILE pteo-20161231_cal.xml EX-101.CAL 32703
8 XBRL DEFINITION FILE pteo-20161231_def.xml EX-101.DEF 53752
9 XBRL LABEL FILE pteo-20161231_lab.xml EX-101.LAB 130857
10 XBRL PRESENTATION FILE pteo-20161231_pre.xml EX-101.PRE 104335
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

EIN.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30728 | Film No.: 17762646
SIC: 2834 Pharmaceutical Preparations